Staphylococcus aureus response and adaptation to vancomycin
Advances in Microbial Physiology · 2024 · 201-258
DOI: 10.1016/bs.ampbs.2024.04.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Microbial Physiology, 2024. Verfasst von Anaëlle Fait und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark; Department of Environmental Systems Science, ETH Züri…. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents, Vancomycin Resistance. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 222 Literaturangaben.
Abstract (Originalsprache)
Antibiotic resistance is an increasing challenge for the human pathogen Staphylococcus aureus. Methicillin-resistant S. aureus (MRSA) clones have spread globally, and a growing number display decreased susceptibility to vancomycin, the favoured antibiotic for treatment of MRSA infections. These vancomycin-intermediate S. aureus (VISA) or heterogeneous vancomycin-intermediate S. aureus (hVISA) strains arise from accumulation of a variety of point mutations, leading to cell wall thickening and reduced vancomycin binding to the cell wall building block, Lipid II, at the septum. They display only minor changes in vancomycin susceptibility, with varying tolerance between cells in a population, and therefore, they can be difficult to detect. In this review, we summarize current knowledge of VISA and hVISA. We discuss the role of genetic strain background or epistasis for VISA development and the possibility of strains being 'transient' VISA with gene expression changes mediated by, for example, VraTSR, GraXSR, or WalRK signal transduction systems, leading to temporary vancomycin tolerance. Additionally, we address collateral susceptibility to other antibiotics than vancomycin. Specifically, we estimate how mutations in rpoB, encoding the β-subunit of the RNA polymerase, affect overall protein structure and compare changes with rifampicin resistance. Ultimately, such in-depth analysis of VISA and hVISA strains in terms of genetic and transcriptional changes, as well as changes in protein structures, may pave the way for improved detection and guide antibiotic therapy by revealing strains at risk of VISA development. Such tools will be valuable for keeping vancomycin an asset also in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark; Department of Environmental Systems Science, ETH Zürich, Zürich, Switzerland.
- Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark.
- Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark. Electronic address: hi@sund.ku.dk.
Zitieren
APA
Fait, A., Silva, S. F., Abrahamsson, J. Å. H., & Ingmer, H. (2024). Staphylococcus aureus response and adaptation to vancomycin. Advances in Microbial Physiology, 201-258. https://doi.org/10.1016/bs.ampbs.2024.04.006
Vancouver
Fait A, Silva SF, Abrahamsson JÅH, Ingmer H. Staphylococcus aureus response and adaptation to vancomycin. Advances in Microbial Physiology. 2024:201-258. doi:10.1016/bs.ampbs.2024.04.006
BibTeX
@article{Fait2024,
author = {Fait, Anaëlle and Silva, Stephanie Fulaz and Abrahamsson, Jack Åke Harry and Ingmer, Hanne},
title = {Staphylococcus aureus response and adaptation to vancomycin},
journal = {Advances in Microbial Physiology},
year = {2024},
pages = {201--258},
doi = {10.1016/bs.ampbs.2024.04.006}
}
EUVIMED